Philips to Acquire Intact Vascular for $360M

 Philips to Acquire Intact Vascular for $360M

Philips to Acquire Intact Vascular for $360M

Shots:

  • Philips will acquire Intact Vascular for $275M up front and deferred payments of $85M upon completion of the transaction. The transaction is expected to be completed in Q3’20
  • The collaboration will expand Philips’ image-guided therapy portfolio with the addition of Intact Vascular’s Tack endovascular system, that reinforces standard and drug-coated balloon PAD treatment results
  • Intact Vascular’s Tack implant is a minimal-metal, dissection repair device that provides precision treatment of peripheral arterial dissections following balloon angioplasty in ATK and BTK therapeutic interventions

Click here ­to­ read full press release/ article | Ref: Philips | Image: Philips

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post